Form 4: Marinus Pharmaceuticals SVP Sells Shares to Cover Tax Obligations

Martha E. Manning, SVP, General Counsel & Corporate Secretary of Marinus Pharmaceuticals, sold 3,621 shares of common stock on August 5, 2024, to cover tax obligations related to vesting restricted stock units.

Summary

• On August 5, 2024, Martha E. Manning, the SVP, General Counsel & Corporate Secretary of Marinus Pharmaceuticals, sold 3,621 shares of the company's common stock.
• The sale was executed at a weighted-average price of $1.13 per share, with individual transactions ranging from $1.11 to $1.16.
• The sale was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on May 16, 2022.
• The purpose of the sale was to cover tax obligations associated with the vesting of restricted stock units.
• Following the transaction, Manning directly owns 60,263 shares of Marinus Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transaction appears to be a routine sale to cover tax obligations under a pre-existing 10b5-1 plan.

Industry Context

This is a routine transaction for covering tax obligations and doesn't necessarily reflect a change in sentiment about the company's prospects.

Key Dates

Keywords

Marinus Pharmaceuticals, MRNS, Martha E. Manning, Stock Sale, Form 4, Rule 10b5-1 Plan, Insider Trading, Tax Obligations, Restricted Stock Units